Washington University and TGR Institute granted MolecularMD exclusive rights to uses of fibroblast growth factor receptor 2 (FGFR2) mutations in human endometrial cancer

Translational Genomics Research Institute

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Washington University in St. Louis

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

MolecularMD Corp.

U.S. / Tools, Services, and Manufacturing

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced